The DOI matches its Crossref record.
Efficacy and Safety of Carbon Ion Radiotherapy in Bone and Soft Tissue Sarcomas
Open accessAbstract
PURPOSE: To evaluate the tolerance for and effectiveness of carbon ion radiotherapy in patients with unresectable bone and soft tissue sarcomas. PATIENTS AND METHODS: We conducted a phase I/II dose escalation study of carbon ion radiotherapy. Fifty-seven patients with 64 sites of bone and soft tissue sarcomas not suited for resection received carbon ion radiotherapy. Tumors involved the spine or paraspinous soft tissues in 19 patients, pelvis in 32 patients, and extremities in six patients. The total dose ranged from 52.8 to 73.6 gray equivalent (GyE) and was administered in 16 fixed fractions over 4 weeks (3.3 to 4.6 GyE/fraction). The median tumor size was 559 cm 3 (range, 20 to 2,290 cm 3). The minimum follow-up was 18 months. RESULTS: Seven of 17 patients treated with the highest total dose of 73.6 GyE experienced Radiation Therapy Oncology Group grade 3 acute skin reactions. Dose escalation was then halted at this level. No other severe acute reactions (grade > 3) were observed in this series. The overall local control rates were 88% and 73% at 1 year and 3 years of follow-up, respectively. The median survival time was 31 months (range, 2 to 60 months), and the 1- and 3-year overall survival rates were 82% and 46%, respectively. CONCLUSION: Carbon ion radiotherapy seems to be a safe and effective modality in the management of bone and soft tissue sarcomas not eligible for surgical resection, providing good local control and offering a survival advantage without unacceptable morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Particle Radiation Therapy Using Proton and Heavier Ion Beams
Schulz-Ertner, D., & Tsujii, H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7816 · Cited by 622
Self-citationLevin, W. P., Kooy, H., Loeffler, J. S., & DeLaney, T. F. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602754 · Cited by 372
OPERATIVE MANAGEMENT OF SACRAL CHORDOMA
FUCHS, B., DICKEY, I. D., YASZEMSKI, M. J., INWARDS, C. Y., & SIM, F. H. (2005) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200510000-00009 · Cited by 362
Effectiveness of Carbon Ion Radiotherapy in the Treatment of Skull-Base Chordomas
Schulz-Ertner, D., Karger, C. P., Feuerhake, A., Nikoghosyan, A., Combs, S. E., Jäkel, O., Edler, L., Scholz, M., & Debus, J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.059 · Cited by 290
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y., Yock, T. I., Ebb, D. H., Choy, E., Raskin, K. A., Liebsch, N., et al. (2011) · Cancer · doi:10.1002/cncr.26037 · Cited by 191
Metadata
- Authors
- Kamada, T., Tsujii, H., Tsuji, H., Yanagi, T., Mizoe, J.-E., Miyamoto, T., Kato, H., Yamada, S., Morita, S., Yoshikawa, K., Kandatsu, S., & Tateishi, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-11-15
- Volume
- 20
- Issue
- 22
- Pages
- 4466-4471
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2143256090
- Cited by
- 289
- References
- 0
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and Safety of Carbon Ion Radiotherapy in Bone and Soft Tissue Sarcomas. https://app.cochat.ai/papers/10.1200/jco.2002.10.050
- The paper
- Kamada, T., Tsujii, H., Tsuji, H., Yanagi, T., Mizoe, J.-E., Miyamoto, T., Kato, H., Yamada, S., Morita, S., Yoshikawa, K., Kandatsu, S., & Tateishi, A. (2002). Efficacy and Safety of Carbon Ion Radiotherapy in Bone and Soft Tissue Sarcomas. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2002.10.050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
